Determinants of Recurrence After Epicardial Ventricular Tachycardia Ablation in Structural Heart Disease.
Angeliki, D., Said-Elias, W., Arash, A., Moneeb, K., Martin, B., Thomas, F., Vanessa, S., Nadica, T., Philipp, L., Ersan, A., Maxim, D., Max, M., Denise, G., Philipp, S., & Christian, S. (2026). Determinants of Recurrence After Epicardial Ventricular Tachycardia Ablation in Structural Heart Disease.. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2026.04.026
Angeliki D, Said-Elias W, Arash A, Moneeb K, Martin B, Thomas F, et al. Determinants of Recurrence After Epicardial Ventricular Tachycardia Ablation in Structural Heart Disease.. Heart Rhythm. 2026; doi: 10.1016/j.hrthm.2026.04.026
Angeliki D, Said-Elias W, Arash A, et al. Determinants of Recurrence After Epicardial Ventricular Tachycardia Ablation in Structural Heart Disease.[J]. Heart Rhythm. 2026. DOI: 10.1016/j.hrthm.2026.04.026.
@article{angeliki2026,
author = {Darma Angeliki and Waezsada Said-Elias and Arya Arash and Khalaph Moneeb and Braun Martin and Fink Thomas and Sciacca Vanessa and Trajkovska Nadica and Lucas Philipp and Akkaya Ersan and Didenko Maxim and Moersdorf Max and Guckel Denise and Sommer Philipp and Sohns Christian},
title = {Determinants of Recurrence After Epicardial Ventricular Tachycardia Ablation in Structural Heart Disease.},
journal = {Heart Rhythm},
year = {2026},
doi = {10.1016/j.hrthm.2026.04.026},
note = {PMID: 42019793},
}
TY - JOUR AU - Darma Angeliki AU - Waezsada Said-Elias AU - Arya Arash AU - Khalaph Moneeb AU - Braun Martin AU - Fink Thomas AU - Sciacca Vanessa AU - Trajkovska Nadica AU - Lucas Philipp AU - Akkaya Ersan AU - Didenko Maxim AU - Moersdorf Max AU - Guckel Denise AU - Sommer Philipp AU - Sohns Christian TI - Determinants of Recurrence After Epicardial Ventricular Tachycardia Ablation in Structural Heart Disease. T2 - Heart Rhythm PY - 2026 DO - 10.1016/j.hrthm.2026.04.026 AN - PMID:42019793 ER -
Epicardial catheter ablation is an established treatment for ventricular tachycardia (VT) in patients with structural heart disease (SHD); however, VT recurrence remains frequent, particularly in advanced cardiomyopathy. To identify clinical and electrophysiological determinants of VT recurrence following epicardial VT ablation in SHD. Seventy-four patients with SHD undergoing epicardial VT ablation were included. Acute procedural outcomes, VT recurrence, and adverse clinical events were assessed. Nonischaemic cardiomyopathy was the predominant etiology. Epicardial scar predominantly involved basal-lateral left ventricular regions with periannular and outflow tract extension. Acute procedural non-inducibility was achieved in 49 patients (66%), while VT recurrence occurred in 37 patients (50%) during follow-up of 17 months. In cause-specific Cox analysis, electrical storm (HR 3.130, 95% CI 1.421-6.893; p=0.005), longer VT cycle length (HR 2.835, 95% CI 1.211-6.638; p=0.016) and higher body mass index (BMI, HR 2.918, 95% CI 1.365-6.236; p=0.006) were independently associated with VT recurrence. During follow-up, 7 patients died, 10 underwent heart transplantation, and 2 required ventricular assist device implantation. Combined endocardial and epicardial VT ablation in advanced SHD was associated with moderate acute success, while VT recurrence remained common during follow-up. Electrical storm, longer VT cycle length, and higher BMI were independently associated with an increased risk of recurrence.